Quantcast

Latest Messenger RNA Stories

2014-06-17 16:25:38

Messenger RNA Therapeutics(TM) leader joins short list of major innovators for potential to transform the treatment of many diseases CAMBRIDGE, Mass., June 17, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), today announced it was named to the 2014 CNBC Disruptor 50 list. CNBC recognizes Moderna as one of the top 50 companies whose innovations are having a dramatic impact across their industries, and are poised for hyper-growth....

2014-06-12 08:29:06

Company Doubles Footprint in Cambridge Due to Rapid Growth CAMBRIDGE, Mass., June 12, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), is announcing the company's expansion to 320 Bent Street in the Kendall Square area of Cambridge, a move that adds nearly 50,000 square feet of office, laboratory and manufacturing facilities to Moderna's operations in Massachusetts. http://photos.prnewswire.com/prnvar/20140611/117232...

2014-05-21 08:29:10

CAMBRIDGE, Mass., May 21, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today the formation of a Technology Advisory Board. This new Technology Advisory Board will bring together a world-class panel of experts to advise Moderna on building state-of-the-art GMP (Good Manufacturing Practice) manufacturing capabilities to...

2014-04-17 15:36:22

A novel application of RNAScope in situ hybridization facilitates gene expression studies in plants Gene expression is the process whereby the genetic information of DNA is used to manufacture functional products, such as proteins, which have numerous different functions in living organisms. Messenger RNA (mRNA) serves as an important intermediary during gene expression, by relating the genetic information of DNA to the molecular mechanisms involved in manufacturing proteins. By...

2014-02-24 12:27:26

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing rare diseases, today announced it will present at BIOCOM's Global Life Science Partnering Conference being held on February 26 and 27, 2014 at the Lodge in Torrey Pines, La Jolla, California. In addition to providing an update on its flagship program targeting transthyretin (TTR)-mediated amyloidosis, Arcturus will present data for its proprietary LUNAR(TM) delivery...

2014-02-07 12:48:23

Protein controls editing, expanding the information content of DNA An international team of researchers, led by scientists from the University of California, San Diego School of Medicine and Indiana University, have identified a protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed and ultimately translated into the myriad of proteins necessary for life. The findings, published today in the journal Cell Reports, help explain how...

2014-02-05 23:03:02

A study led by St. Jude Children’s Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS Memphis, Tenn. (PRWEB) February 05, 2014 St. Jude Children’s Research Hospital scientists led a study showing that mutations in a gene responsible for amyotrophic lateral sclerosis (ALS) disrupt the RNA transport system in nerve cells. The findings appear in the current issue of the scientific journal Neuron and offer a new focus for...

2014-01-30 08:30:19

- Arcturus proprietary LUNAR(TM) delivery technology demonstrates exceptional potency in vivo, ED(50) of 0.020 mg/kg SAN DIEGO, Jan. 30, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc. today announced it will present a poster at the Keystone Symposia Conference on RNA Silencing held January 31- February 5, 2014 in Seattle, Washington. The Arcturus poster titled "Design of a Novel, Potent, and Safe RNA Therapeutic Platform Utilizing LUNAR(TM) Delivery Technology" (poster...

Isolating RNA From Live Cells In Their Natural Tissue Environment
2014-01-13 07:23:08

University of Pennsylvania School of Medicine Findings allow for better understanding of how tissue microenvironment affects gene expression in healthy and diseased cells A multi-disciplinary team from the University of Pennsylvania have published in Nature Methods a first-of-its-kind way to isolate RNA from live cells in their natural tissue microenvironment without damaging nearby cells. This allows the researchers to analyze how cell-to-cell chemical connections influence individual...

2014-01-10 08:23:49

SEATTLE, Jan. 10, 2014 /PRNewswire/ -- PhaseRx, Inc., an RNA therapeutics company, today announced the appointment of Michael Houston, Ph.D., as its Vice President, Therapeutics Development. (Logo: http://photos.prnewswire.com/prnh/20140110/SF44129LOGO) Dr. Houston brings more than two decades of experience in the manufacturing and development of peptide and oligonucleotide-based therapeutics to PhaseRx. He has directed numerous programs ranging from research to GMP manufacture of...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related